Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Leukemia, Myeloid, Acute 29Myelodysplastic Syndromes 10Advanced Solid Tumors 8Leukemia, Myelomonocytic, Chronic 6Myeloproliferative Disorders 5Advanced Solid Tumor 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Neoplasms 4Advanced Solid Tumour 4Multiple Myeloma 3Lung Neoplasms 3Leukemia, Monocytic, Acute 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumor 2Small Cell Lung Carcinoma 2Recurrence 2Prostatic Neoplasms 2Primary Myelofibrosis 2Polycythemia Vera 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Leukemia, Biphenotypic, Acute 2Breast Neoplasms 2Biliary Tract Neoplasms 2Advanced Malignant Solid Tumor 2

Interventions

Magnetic Resonance Spectroscopy 56enzalutamide 44Specimen Handling 37apalutamide 35Androgen Antagonists 35Abiraterone Acetate 29Prednisone 27Radiosurgery 26darolutamide 25Docetaxel 23Pluvicto 22abiraterone 21Radiotherapy 21Leuprolide 20Biopsy 16relugolix 14acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14gallium 68 PSMA-11 12Triptorelin Pamoate 12Surveys and Questionnaires 12Radiation 12Gonadotropin-Releasing Hormone 12X-Rays 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 10cabazitaxel 9bicalutamide 9Standard of Care 9Nivolumab 9Goserelin 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Injections × 90 days × Clear all
NCT06282588 2026-03-19

THUNDER

Cancer Research Antwerp

Phase 2/3 Recruiting
493 enrolled
Genitourinary

Prostatic Neoplasms

NCT07230106 2026-03-03

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Recruiting
218 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡